Real-time enrollment status for this locally advanced /metastatic solid tumors clinical trial
Current Status
Recruiting
Checked: November 5, 2026 at 4:54 PM UTC
| NCT Number | NCT07857616 |
| Recruiting Status | Recruiting |
| Condition | Locally Advanced /Metastatic Solid Tumors |
| Phase | PHASE1 |
| Target Enrollment | 424 participants |
| Active Locations | 7 sites in the US |
| Sponsor | SystImmune Inc. |
| Last Updated on CT.gov | November 4, 2026 (Yesterday) |
As of November 5, 2026: Clinical trial NCT07857616 is currently recruiting participants. This phase1 study for locally advanced /metastatic solid tumors is actively seeking new participants at 7 locations across the United States. The study is sponsored by SystImmune Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07857616 is actively recruiting participants as of November 5, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 7 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07857616 was last updated Yesterday (November 4, 2026). HelloStudys verifies this status automatically.